⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18059729 | 0.77 | L3MBTL1 (0.36) | — | |
| SCHEMBL4257786 | 0.77 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL5700020 | 0.77 | ALOX5AP (0.38) | — | |
| SCHEMBL5640712 | 0.74 | — | — | |
| SCHEMBL10833630 | 0.74 | L3MBTL1 (0.47) | — | |
| SCHEMBL24645057 | 0.73 | — | — | |
| SCHEMBL4987729 | 0.73 | — | — | |
| SCHEMBL3168798 | 0.73 | — | — | |
| SCHEMBL2140617 | 0.73 | — | — | |
| SCHEMBL18716442 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719394-A2 | INHIBITORS OF TYK2 | Atomwise Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260048051-A1 | TREATMENT OF INFLAMMATORY BOWEL DISEASE | ATOMWISE INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12358904-B2 | Inhibitors of TYK2 | Atomwise Inc. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20240425484-A1 | INHIBITORS OF TYK2 | Atomwise Inc. | 2024-12-26 | — | — | US | disclosed |
| US-20240417396-A1 | INHIBITORS OF TYK2 | Atomwise Inc. | 2024-12-19 | — | — | US | disclosed |
| WO-2024250010-A2 | INHIBITORS OF TYK2 | Atomwise Inc. (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2023146512-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2020-07-02 | — | — | US | disclosed |
| EP-3538091-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | Navitor Pharmaceuticals, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2012116242-A1 | THIAZOLE AND OXOZOLE CARBENE METAL COMPLEXES AS PHOSPHORESCENT OLED MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-08-30 | — | — | WO | disclosed |
| US-20120212126-A1 | THIOAZOLE AND OXAZOLE CARBENE METAL COMPLEXES AS PHOSPHORESCENT OLED MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-08-23 | — | — | US | disclosed |
| US-20120212126-A1 | THIOAZOLE AND OXAZOLE CARBENE METAL COMPLEXES AS PHOSPHORESCENT OLED MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-08-23 | — | — | US | disclosed |
| CN-102639500-A | Tricyclic compound, preparation method and pharmaceutical use thereof | SHANGHAI HENGRUI PHARM CO LTD | 2012-08-15 | — | — | CN | disclosed |
| US-20100227889-A1 | Benzimidazole Derivatives | NOVARTIS AG (CH) | 2010-09-09 | — | — | US | disclosed |
| US-20100227889-A1 | Benzimidazole Derivatives | NOVARTIS AG (CH) | 2010-09-09 | — | — | US | disclosed |
| US-20100227889-A1 | Benzimidazole Derivatives | NOVARTIS AG (CH) | 2010-09-09 | — | — | US | disclosed |
| EP-2004629-A2 | BENZIMIDAZOLE DERIVATIVES | Novartis AG (CH) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007112913-A2 | BENZIMIDAZOLE DERIVATIVES | NOVARTIS AG (CH) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007112913-A2 | BENZIMIDAZOLE DERIVATIVES | NOVARTIS AG (CH) | 2007-10-11 | — | — | WO | disclosed |